ACE2 and COVID-19: Imai et al24 found that rhACE2 protein treatment could reduce plasma Ang II levels and reduce lung injury in ACE2 knockout mice and wild-type mice, so we speculate that rhACE2 may become one of the most promising approaches for future treatment and improve the prognosis of patients with COVID-19.